The joint and individual correlations of CVD/T2D and BMI with cancer risk.
Advancing hepatic cell carcinoma treatment through mitochondrial DNA targeting
Hepatic cell carcinoma (HCC), the fifth most prevalent malignancy worldwide and the fourth leading cause of cancer-related mortality, poses significant therapeutic challenges.